Envestnet Asset Management Inc Vericel Corp Transaction History

Envestnet Asset Management Inc

$326 Billion
Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in Vericel Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 227,634 shares of VCEL stock, worth $7.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

227,634

Previous 204,510 11.31%

Holding current value

$7.89 Million

Previous $9.13 Million 6.14%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$37.92 - $45.7 $876,862 - $1.06 Million	23,124 Added 11.31%	227,634 $9.69 Million
Q1 2025 Apr 29, 2025	BUY	$44.5 - $61.8 $1.22 Million - $1.7 Million	27,526 Added 15.55%	204,510 $9.13 Million
Q4 2024 Feb 12, 2025	SELL	$40.05 - $59.11 $136,730 - $201,801	-3,414 Reduced 1.89%	176,984 $9.72 Million
Q3 2024 Nov 06, 2024	BUY	$42.25 - $53.56 $937,654 - $1.19 Million	22,193 Added 14.03%	180,398 $7.62 Million
Q2 2024 Aug 08, 2024	BUY	$41.71 - $52.9 $286,672 - $363,581	6,873 Added 4.54%	158,205 $7.26 Million
Q1 2024 May 13, 2024	BUY	$32.52 - $52.33 $811,471 - $1.31 Million	24,953 Added 19.74%	151,332 $7.87 Million
Q4 2023 Feb 13, 2024	SELL	$30.85 - $37.09 $123 - $148	-4 Reduced -0.0%	126,379 $4.5 Million
Q3 2023 Nov 13, 2023	BUY	$31.69 - $39.25 $1.41 Million - $1.75 Million	44,507 Added 54.36%	126,383 $4.24 Million
Q2 2023 Aug 04, 2023	BUY	$29.0 - $38.37 $36,714 - $48,576	1,266 Added 1.57%	81,876 $3.08 Million
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $107,778 - $141,625	4,519 Added 5.94%	80,610 $2.36 Million
Q4 2022 Feb 07, 2023	SELL	$17.65 - $27.37 $260,796 - $404,419	-14,776 Reduced 16.26%	76,091 $2 Million
Q3 2022 Nov 10, 2022	BUY	$22.62 - $32.54 $211,836 - $304,737	9,365 Added 11.49%	90,867 $2.11 Million
Q2 2022 Aug 03, 2022	SELL	$22.88 - $39.45 $53,104 - $91,563	-2,321 Reduced 2.77%	81,502 $2.05 Million
Q1 2022 May 04, 2022	BUY	$31.69 - $43.29 $2.08 Million - $2.84 Million	65,700 Added 362.52%	83,823 $3.2 Million
Q4 2021 Feb 04, 2022	SELL	$35.2 - $52.6 $216,620 - $323,700	-6,154 Reduced 25.35%	18,123 $712,000
Q3 2021 Oct 07, 2021	BUY	$46.35 - $59.75 $168,482 - $217,191	3,635 Added 17.61%	24,277 $1.19 Million
Q2 2021 Aug 04, 2021	BUY	$47.2 - $67.81 $529,300 - $760,421	11,214 Added 118.94%	20,642 $1.08 Million
Q1 2021 May 04, 2021	BUY	$30.93 - $59.48 $291,608 - $560,777	9,428 New	9,428 $524,000

Others Institutions Holding VCEL

# of Institutions

294

Shares Held

54M

Call Options Held

35.6K

Put Options Held

7.7K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.63B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Vericel Corp Transaction History